⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ICCM News
IceCure Medical Ltd. Ordinary Shares
IceCure Receives Regulatory Approval in Israel for its Next-Generation XSense™ Cryoablation System for Breast Cancer and Other Indications
prnewswire.com
ICCM
ICCM
Two New Publications from the Independent THERMAC Trial Featuring IceCure's ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate
prnewswire.com
ICCM
ICCM